We performed a retrospective review of patients who were excluded from preapproval trials of coronary IVL and underwent CAC modification with the off-label use of a peripheral IVL system.
Our aim was to identify patients undergoing complex, high-risk indicated percutaneous coronary intervention (CHIP-PCI) and compare their outcomes with non-CHIP patients. We created a CHIP score to risk stratify these patients.
The goal of this study was to determine the utility of intravascular ultrasound for patients with congenital heart disease and pulmonary vein stenosis.
Newer antiplatelet therapy agents are reliable and have a fast onset of action, but have significantly higher cost, leading to compliance concerns. We adopted and evaluated an acute agent-switching strategy, using prasugrel or ticagrelor for rapid…
Anomalous origin of the right coronary artery (ARCA) represents the most common form of abnormal coronary origin and may potentially increase the risk for sudden cardiac death. We aimed to evaluate the feasibility of QFR analysis in patients with…
There is renewed interest in intra-aortic balloon pump (IABP) use in chronic systolic heart failure patients with acute decompensation and cardiogenic shock. We sought to identify predictors of early IABP response to guide optimal use in this…
We evaluate the role of a double bioresorbable vascular scaffold (BVS) strategy in coronary bifurcations, alone or in combination with a dedicated bifurcation device.
Due to high rates of transcatheter mitral valve replacement (TMVR) screening failure, a substantial proportion of patients with severe mitral regurgitation (MR) remain on optimal medical treatment only. This study aimed to assess characteristics and…
Our objective was to determine the occurrence of vascular complications following transfemoral transcatheter aortic valve replacement with new-generation devices according to the use of a crossover technique.
